Benefits Of RSV Vaccination Outweigh Risks For Older Adults, Study Finds

Infectious Disease Advisor (7/2, Chan) reports, “Although Guillain-Barré syndrome rates were higher than expected among older adults following respiratory syncytial virus (RSV) vaccination, the benefits of the RSV vaccine outweigh the potential risks in this population. These study results were published in [the] Morbidity and Mortality Weekly Report.” The study found “the most frequently reported symptoms following RSV vaccination were pain at or near the injection site (31%), fatigue or tiredness (20.5%), and muscle or body aches (17.5%).”